Patient centric blood sampling and analysis for diagnostics and laboratory medicine

Blood sampling and diagnostic laboratory analysis are important aspects of our healthcare systems and patient management. However, the process by which the majority of blood specimens are currently collected, venipuncture, does not put the needs of the patient at the center of the process. This article explores the potential utilization of patient centric sampling (PCS) for the collection of smaller blood volumes using technologies that can enable this sampling to take place at a time and location that is more comfortable and convenient for the patient, including self-sampling at home. We discuss the benefits of these technologies, where they are currently used (including case studies), what to consider when contemplating their use and the current regulatory environment. We then explore why the routine adoption of these technologies has been relatively slow and how this impasse may be overcome for the benefit of all patients. This article describes a viable alternative approach for the collection of diagnostic specimens that puts the requirements of the patient at the center. It provides an invaluable resource for those interested in learning about and potentially implementing this approach into their workflows and addresses the concerns that individuals and organizations may have when doing so.

Authors

Institutions

Publication Details

Journal
Bioanalysis
Published
2025-10-09
DOI
https://doi.org/10.1080/17576180.2025.2572289
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient centric blood sampling and analysis for diagnostics and laboratory medicine

Georgios Theodoridis, Neil Spooner, Julia Maroto‐García, Chiara Rospo et al.
Bioanalysis
Biosimilars and Bioanalytical Methods
article

Patient centric blood sampling and analysis for diagnostics and laboratory medicine

Georgios Theodoridis, Neil Spooner, Julia Maroto‐García, Chiara Rospo, Ping Gong, Bradley B. Collier, Rachel S. Carling, Elizabeth R. Rayburn, Daniel Baker, M S Strom
article en

Abstract

Blood sampling and diagnostic laboratory analysis are important aspects of our healthcare systems and patient management. However, the process by which the majority of blood specimens are currently collected, venipuncture, does not put the needs of the patient at the center of the process. This article explores the potential utilization of patient centric sampling (PCS) for the collection of smaller blood volumes using technologies that can enable this sampling to take place at a time and location that is more comfortable and convenient for the patient, including self-sampling at home. We discuss the benefits of these technologies, where they are currently used (including case studies), what to consider when contemplating their use and the current regulatory environment. We then explore why the routine adoption of these technologies has been relatively slow and how this impasse may be overcome for the benefit of all patients. This article describes a viable alternative approach for the collection of diagnostic specimens that puts the requirements of the patient at the center. It provides an invaluable resource for those interested in learning about and potentially implementing this approach into their workflows and addresses the concerns that individuals and organizations may have when doing so.

BioanalysisVol. 17(20)
St Thomas' Hospital (GB), Bon Secours Health System (US), Aristotle University of Thessaloniki (GR), LabCorp (United States) (US), Interscience Communications (United Kingdom) (GB), System Science Applications (United States) (US), AstraZeneca (Singapore) (SG), Birmingham VA Medical Center (US), St. Thomas Hospital (CA), AstraZeneca (Switzerland) (CH), AstraZeneca (Japan) (JP), St. Luke's Magic Valley Medical Center (US), Clinica Universidad de Navarra (ES), Capita (United Kingdom) (GB), Groupement d'Intérêt Economique (FR), Biocrine (Sweden) (SE), UCB Pharma (Belgium) (BE)
Openalex Percentile: Top 70%
Biosimilars and Bioanalytical Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.